ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
MINNEAPOLIS, Dec. 3, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved ...
My brain injury in 2000 affected my balance and gait. Doctors assessed it by asking me to walk across a small room and back again. Aside from that observational method, which would not have apprised ...
Neurolief, a neuroscience-driven medical technology company focused on non-invasive neuromodulation therapies, has secured a $6 million milestone-based investment from BrainsWay following FDA ...
Editor's note: MobiHealthNews was recently informed by the company that while the story was based on information released by Wavegate at the time, the investment did not materialize. (April 27, 2026) ...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
BlueWind Medical, developer of the Revi® System for urgency urinary incontinence (UUI), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved a new Category I ...
The company said its neuromodulation therapy can be delivered 24 hours a day, seven days a week, with weekly charging sessions. (Getty Images) After putting forward preliminary clinical data earlier ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...
In an article published in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD). The ...
LITTLE ROCK, Ark. (KATV) — For people living with depression, medication and therapy can be life-changing. But for others, those traditional options don’t work, a condition doctors call ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...
Salvia BioElectronics has raised €53m ($60m) in a Series B funding round towards advancing its non-invasive approach to treating chronic migraine. The Dutch startup’s MySalvia therapy for individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results